Biodexa Pharmaceuticals Statistics
Total Valuation
BDRX has a market cap or net worth of $515,818. The enterprise value is -$3.77 million.
| Market Cap | 515,818 |
| Enterprise Value | -3.77M |
Important Dates
The last earnings date was Friday, September 11, 2026, after market close.
| Earnings Date | Sep 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BDRX has 128,633 shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 128,633 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.15% |
| Owned by Institutions (%) | 8.10% |
| Float | 1.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.03 |
| P/TBV Ratio | 0.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.41, with zero debt.
| Current Ratio | 2.41 |
| Quick Ratio | 2.41 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -58.15 |
Financial Efficiency
Return on equity (ROE) is -42.00% and return on invested capital (ROIC) is -138.48%.
| Return on Equity (ROE) | -42.00% |
| Return on Assets (ROA) | -40.11% |
| Return on Invested Capital (ROIC) | -138.48% |
| Return on Capital Employed (ROCE) | -88.89% |
| Weighted Average Cost of Capital (WACC) | 11.31% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$533,127 |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BDRX has paid $137,986 in taxes.
| Income Tax | 137,986 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.66% in the last 52 weeks. The beta is 1.28, so BDRX's price volatility has been higher than the market average.
| Beta (5Y) | 1.28 |
| 52-Week Price Change | -98.66% |
| 50-Day Moving Average | 5.83 |
| 200-Day Moving Average | 26.20 |
| Relative Strength Index (RSI) | 44.22 |
| Average Volume (20 Days) | 526,258 |
Short Selling Information
The latest short interest is 18,380, so 0.10% of the outstanding shares have been sold short.
| Short Interest | 18,380 |
| Short Previous Month | 271,866 |
| Short % of Shares Out | 0.10% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -6.92M |
| Operating Income | -11.73M |
| Pretax Income | -5.73M |
| Net Income | -5.86M |
| EBITDA | -11.74M |
| EBIT | -11.73M |
| Earnings Per Share (EPS) | -$102.50 |
Balance Sheet
The company has $4.29 million in cash and no debt, with a net cash position of $4.29 million or $33.32 per share.
| Cash & Cash Equivalents | 4.29M |
| Total Debt | n/a |
| Net Cash | 4.29M |
| Net Cash Per Share | $33.32 |
| Equity (Book Value) | 12.75M |
| Book Value Per Share | 136.76 |
| Working Capital | 5.19M |
Cash Flow
In the last 12 months, operating cash flow was -$9.17 million and capital expenditures -$9,303, giving a free cash flow of -$9.18 million.
| Operating Cash Flow | -9.17M |
| Capital Expenditures | -9,303 |
| Depreciation & Amortization | -10,632 |
| Net Borrowing | -700,373 |
| Free Cash Flow | -9.18M |
| FCF Per Share | -$71.34 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BDRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -2,556.23% |
| FCF Yield | -1,815.25% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 26, 2026. It was a reverse split with a ratio of 1:8.
| Last Split Date | Oct 26, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |